Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease.

Chandrakumar, Abin; Georgy, Michael; Agarwal, Prasoon; 't Jong, Geert W; El-Matary, Wael

Chandrakumar, Abin; Georgy, Michael; Agarwal, Prasoon; 't Jong, Geert W; El-Matary, Wael.

Affiliation

Chandrakumar A; Department of Pharmacology and Therapeutics, University of Manitoba.
Georgy M; Clinical Research Unit, Children's Hospital Research Institute of Manitoba.
Agarwal P; Section of Pediatric Gastroenterology, Winnipeg Children's Hospital, Max Rady College of Medicine, Rady Faculty of Health Sciences and Children's Hospital Research Institute.
't Jong GW; Section of Pediatric Gastroenterology, Winnipeg Children's Hospital, Max Rady College of Medicine, Rady Faculty of Health Sciences and Children's Hospital Research Institute.
El-Matary W; Department of Pharmacology and Therapeutics, University of Manitoba.

J Pediatr Gastroenterol Nutr ; 69(1): 82-87, 2019 07.

Article in En | MEDLINE | ID: mdl-30789863

Subject(s)

Antibodies, Fungal/blood; Crohn Disease/blood; Crohn Disease/drug therapy; Immunoglobulin G/blood; Adalimumab/therapeutic use; Adolescent; Antibodies, Antineutrophil Cytoplasmic/blood; Biomarkers/blood; Child; Female; Gastrointestinal Agents/therapeutic use; Humans; Immunoglobulin A/blood; Infliximab/therapeutic use; Longitudinal Studies; Male; Prognosis; Prospective Studies; Recurrence; Saccharomyces cerevisiae/immunology; Severity of Illness Index; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Crohn Disease / Antibodies, Fungal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Pediatr Gastroenterol Nutr Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google